These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

577 related items for PubMed ID: 32000660

  • 21. Aspirin-Induced Chemoprevention and Response Kinetics Are Enhanced by PIK3CA Mutations in Colorectal Cancer Cells.
    Zumwalt TJ, Wodarz D, Komarova NL, Toden S, Turner J, Cardenas J, Burn J, Chan AT, Boland CR, Goel A.
    Cancer Prev Res (Phila); 2017 Mar; 10(3):208-218. PubMed ID: 28154202
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Targeting the PI3K/Akt/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases.
    Ippen FM, Grosch JK, Subramanian M, Kuter BM, Liederer BM, Plise EG, Mora JL, Nayyar N, Schmidt SP, Giobbie-Hurder A, Martinez-Lage M, Carter SL, Cahill DP, Wakimoto H, Brastianos PK.
    Neuro Oncol; 2019 Nov 04; 21(11):1401-1411. PubMed ID: 31173106
    [Abstract] [Full Text] [Related]

  • 24. PIK3CA mutations-mediated downregulation of circLHFPL2 inhibits colorectal cancer progression via upregulating PTEN.
    Chong X, Chen J, Zheng N, Zhou Z, Hai Y, Chen S, Zhang Y, Yu Q, Yu S, Chen Z, Bao W, Quan M, Chen ZS, Zhan Y, Gao Y.
    Mol Cancer; 2022 May 26; 21(1):118. PubMed ID: 35619132
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A novel PI3K axis selective molecule exhibits potent tumor inhibition in colorectal carcinogenesis.
    Hussain A, Qazi AK, Mupparapu N, Kumar A, Mintoo MJ, Mahajan G, Sharma PR, Singh SK, Bharate SB, Zargar MA, Ahmed QN, Mondhe DM, Vishwakarma RA, Hamid A.
    Mol Carcinog; 2016 Dec 26; 55(12):2135-2155. PubMed ID: 26764221
    [Abstract] [Full Text] [Related]

  • 27. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
    Liu B, Liu Y, Zhao L, Pan Y, Shan Y, Li Y, Jia L.
    Mol Carcinog; 2017 Dec 26; 56(12):2669-2680. PubMed ID: 28767179
    [Abstract] [Full Text] [Related]

  • 28. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
    Pei Q, Liu GS, Li HP, Zhang Y, Xu XC, Gao H, Zhang W, Li T.
    Eur Rev Med Pharmacol Sci; 2019 Nov 26; 23(22):9871-9881. PubMed ID: 31799655
    [Abstract] [Full Text] [Related]

  • 29. Functional characterization of PI3K C2 domain mutations detected in breast cancer circulating tumor cells and metastatic cells.
    Smit DJ, Brauer H, Horn S, Yigit G, Haider MT, Pogenberg V, Schumacher U, Pantel K, Jücker M.
    Cell Signal; 2024 Sep 26; 121():111270. PubMed ID: 38909932
    [Abstract] [Full Text] [Related]

  • 30. Specific inhibition of p110α subunit of PI3K: putative therapeutic strategy for KRAS mutant colorectal cancers.
    Fernandes MS, Melo S, Velho S, Carneiro P, Carneiro F, Seruca R.
    Oncotarget; 2016 Oct 18; 7(42):68546-68558. PubMed ID: 27602501
    [Abstract] [Full Text] [Related]

  • 31. Long noncoding RNA HAGLROS regulates apoptosis and autophagy in colorectal cancer cells via sponging miR-100 to target ATG5 expression.
    Zheng Y, Tan K, Huang H.
    J Cell Biochem; 2019 Mar 18; 120(3):3922-3933. PubMed ID: 30430634
    [Abstract] [Full Text] [Related]

  • 32. Deoxyshikonin isolated from Arnebia euchroma inhibits colorectal cancer by down-regulating the PI3K/Akt/mTOR pathway.
    Zhu Y, Zhong Y, Long X, Zhu Z, Zhou Y, Ye H, Zeng X, Zheng X.
    Pharm Biol; 2019 Dec 18; 57(1):412-423. PubMed ID: 31230505
    [Abstract] [Full Text] [Related]

  • 33. Dual PI3K/mTOR inhibitor PKI-402 suppresses the growth of ovarian cancer cells by degradation of Mcl-1 through autophagy.
    Hu X, Xia M, Wang J, Yu H, Chai J, Zhang Z, Sun Y, Su J, Sun L.
    Biomed Pharmacother; 2020 Sep 18; 129():110397. PubMed ID: 32585451
    [Abstract] [Full Text] [Related]

  • 34. DRAM1 regulates autophagy and cell proliferation via inhibition of the phosphoinositide 3-kinase-Akt-mTOR-ribosomal protein S6 pathway.
    Lu T, Zhu Z, Wu J, She H, Han R, Xu H, Qin ZH.
    Cell Commun Signal; 2019 Mar 22; 17(1):28. PubMed ID: 30902093
    [Abstract] [Full Text] [Related]

  • 35. The synergistic anti-proliferative effect of the combination of diosmin and BEZ-235 (dactolisib) on the HCT-116 colorectal cancer cell line occurs through inhibition of the PI3K/Akt/mTOR/NF-κB axis.
    Helmy MW, Ghoneim AI, Katary MA, Elmahdy RK.
    Mol Biol Rep; 2020 Mar 22; 47(3):2217-2230. PubMed ID: 32088816
    [Abstract] [Full Text] [Related]

  • 36. Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
    Yin F, Huang X, Xuan Y.
    Dis Markers; 2021 Mar 22; 2021():9950663. PubMed ID: 34512817
    [Abstract] [Full Text] [Related]

  • 37. Tumor suppressive effect of scavenger receptor class A member 5 overexpression in colorectal cancer by regulating PI3K/AKT/mTOR pathway.
    Li Y, Peng F, Tan X, Wang J, Xu Y.
    Genes Genomics; 2021 Oct 22; 43(10):1189-1198. PubMed ID: 34417976
    [Abstract] [Full Text] [Related]

  • 38. H3K9ac modification was involved in doxorubicin induced apoptosis by regulating Pik3ca transcription in H9C2 cells.
    Yang L, Yu Y, Tian G, Deng H, Yu B.
    Life Sci; 2021 Nov 01; 284():119107. PubMed ID: 33508292
    [Abstract] [Full Text] [Related]

  • 39. Antitumor activity of curcumin by modulation of apoptosis and autophagy in human lung cancer A549 cells through inhibiting PI3K/Akt/mTOR pathway.
    Liu F, Gao S, Yang Y, Zhao X, Fan Y, Ma W, Yang D, Yang A, Yu Y.
    Oncol Rep; 2018 Mar 01; 39(3):1523-1531. PubMed ID: 29328421
    [Abstract] [Full Text] [Related]

  • 40. Activation of endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance of human small cell lung cancer cells by inhibiting the PI3K/AKT/mTOR signaling pathway.
    Yu XS, Du J, Fan YJ, Liu FJ, Cao LL, Liang N, Xu DG, Zhang JD.
    Oncotarget; 2016 Nov 22; 7(47):76827-76839. PubMed ID: 27765907
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.